… RH, Liang S, Niyonzima N, De Silva Feelixge HS, Roychoudhury P, Greninger AL, Weber
ND, Boissel S, Scharenberg AM, Cheng A, Magaret A, Bumgarner R, Stone D, and Jerome KR. …

Many obstacles still stand in the way to eliciting an effective immune response against cancer,
even though several antigens and antigenic peptides have been identified as potential …

Unlike quantitative polymerase chain reaction (qPCR), digital PCR (dPCR) achieves sensitive
and accurate absolute quantitation of a DNA sample without the need for a standard curve…

Background Community transmission of coronavirus 2019 (Covid-19) was detected in the
state of Washington in February 2020. Methods We identified patients from nine Seattle-area …

Detection of SARS-CoV-2 with a CRISPR-Based Test A new method for the detection of
SARS-CoV-2 combines simplified extraction of RNA with isothermal amplification and CRISPR (…

The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies on …

Nearly 400,000 people worldwide are known to have been infected with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) beginning in December 2019. The virus has …

Coronavirus disease 2019 (COVID-19), the novel respiratory illness caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with severe morbidity and …

Objective Our objective was to test whether natalizumab, an antibody against very late
activating antigen (VLA)‐4, interferes with central nervous system immune surveillance as …

The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the
United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 …